Earth Science TechETST +25.56%37 3-Year ROIIC % is 215.69 as of Mar. 2026, which is 132% above its 10-year median of 92.98. GuruFocus rates ETST with a GF Score™ of 37/100 and a GF Value™ of $0.24 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 944 Drug Manufacturers companies, Earth Science Tech ranks better than 94.92% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Earth Science Tech's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 215.69%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Earth Science Tech's 3-Year ROIIC % or its related term are showing as below:
ETST's 3-Year ROIIC % is ranked better than 94.92% of 944
companies
in the Drug Manufacturers industry
Industry Median: 3.72
vs ETST: 215.69
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Earth Science Tech 3-Year ROIIC % Related Terms
Earth Science Tech 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Earth Science Tech's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETST vs IXHL, BTAI, TLPH: 3-Year ROIIC % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Earth Science Tech's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earth Science Tech 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Earth Science Tech's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Earth Science Tech's 3-Year ROIIC % falls into.
Earth Science Tech's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 4.315 (Mar. 2026) - -0.937 (Mar. 2023) )
/
( 5.79 (Mar. 2026) - 3.355 (Mar. 2023) )
=
5.252
/
2.435
=
215.69%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Earth Science Tech (ETST) has a 3-Year ROIIC % of 215.69 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Earth Science Tech and its competitors. This is 132% above median its historical median of 92.98. According to the industry distribution chart, Earth Science Tech ranks #48 out of 944 companies in the Drug Manufacturers industry, placing it in the top 5.1%.
Is Earth Science Tech's 3-Year ROIIC % too high?
Earth Science Tech's current 3-Year ROIIC % of 215.69 is 132% above median its 10-year median of 92.98. The Drug Manufacturers industry median 3-Year ROIIC % is 3.72. Earth Science Tech's value of 215.69 is 5698.1% above this industry median. Based on the distribution chart, Earth Science Tech ranks #48 out of 944 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Earth Science Tech has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Earth Science Tech's 3-Year ROIIC % compare to IXHL and BTAI?
According to the Drug Manufacturers industry distribution chart, Earth Science Tech ranks #48 out of 944 companies for 3-Year ROIIC %. This places Earth Science Tech in the top 5% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.72. Earth Science Tech's value of 215.69 is 5698.1% above this benchmark. While the company's 10-year median is 92.98 vs. the industry median of 3.72, Earth Science Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.72, based on 944 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Science Tech's current 3-Year ROIIC % of 215.69 is 5698.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Earth Science Tech and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Science Tech's current 3-Year ROIIC % is 215.69, which is 132% above median its own 10-year median of 92.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Science Tech stock overvalued right now?
Based on GuruFocus' analysis, Earth Science Tech (ETST) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.24, compared to a current price of $0.17 — trading 29.4% below its estimated fair value. The current 3-Year ROIIC % is 215.69, which is 132% above median its 10-year median of 92.98 and 5698.1% above the Drug Manufacturers industry median of 3.72. Earth Science Tech's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Earth Science Tech (ETST), the current 3-Year ROIIC % is 215.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Earth Science Tech (ETST) Overvalued in 2026?
Based on GuruFocus' analysis, Earth Science Tech stock appears to be undervalued.
The current stock price of $0.17 is trading 29.4% below its estimated GF Value™ of $0.24.
GuruFocus considers Earth Science Tech to be Modestly Undervalued.
Key valuation signals for ETST:
3-Year ROIIC %: 215.69 (132% above median its 10-year median of 92.98)
GF Value™: $0.24 vs. price of $0.17 (29.4% below fair value)
Industry Position: 5698.1% above the Drug Manufacturers median (#48 of 944)
No single metric tells the full story. See the ETST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Earth Science Tech Inc is a diversified holding company. The company focuses on the health and wellness sector. The Company's principal operating plan is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment.
37GF Score
Get the complete analysis for ETST
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ETST has been successfully added to your 
